Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
58.4%
operating margin TTM
-0.8%
revenue TTM
292.62 Million
revenue per share TTM
4.71$
valuation ratios | |
|---|---|
| pe ratio | 25.86 |
| peg ratio | 0.06 |
| price to book ratio | 26.74 |
| price to sales ratio | 15.16 |
| enterprise value multiple | 1,037.22 |
| price fair value | 26.74 |
profitability ratios | |
|---|---|
| gross profit margin | 88.17% |
| operating profit margin | -0.8% |
| pretax profit margin | -19.34% |
| net profit margin | 58.4% |
| return on assets | 25.26% |
| return on equity | -5641.9% |
| return on capital employed | -0.79% |
liquidity ratios | |
|---|---|
| current ratio | 1.00 |
| quick ratio | 0.72 |
| cash ratio | 0.51 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 1,119.18 |
| operating cycle | 1,201.99 |
| days of payables outstanding | 279.80 |
| cash conversion cycle | 922.19 |
| receivables turnover | 4.41 |
| payables turnover | 1.30 |
| inventory turnover | 0.33 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.45 |
| debt equity ratio | 1.84 |
| long term debt to capitalization | 0.44 |
| total debt to capitalization | 0.65 |
| interest coverage | -0.04 |
| cash flow to debt ratio | 0.06 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.68 |
| cash per share | 9.30 |
| operating cash flow per share | 0.93 |
| free cash flow operating cash flow ratio | 0.73 |
| cash flow coverage ratios | 0.06 |
| short term coverage ratios | 0.11 |
| capital expenditure coverage ratio | 3.71 |
Frequently Asked Questions
When was the last time Ascendis Pharma A/S (NASDAQ:ASND) reported earnings?
Ascendis Pharma A/S (ASND) published its most recent earnings results on 07-05-2026.
What is Ascendis Pharma A/S's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ascendis Pharma A/S (NASDAQ:ASND)'s trailing twelve months ROE is -5641.9%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ascendis Pharma A/S (ASND) currently has a ROA of 25.26%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ASND's net profit margin stand at?
ASND reported a profit margin of 58.4% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ASND's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.00 in the most recent quarter. The quick ratio stood at 0.72, with a Debt/Eq ratio of 1.84.